Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

6.20
+0.46508.12%
Post-market: 6.17-0.0250-0.40%19:55 EDT
Volume:4.67M
Turnover:29.06M
Market Cap:552.24M
PE:-2.95
High:6.58
Open:5.85
Low:5.77
Close:5.73
Loading ...
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Oct 16, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report